首页> 外国专利> PLASMA BIOMARKER COMPOSITION FOR DISTINGUISHING ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (AECOPD) FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND DETECTION METHOD USING SAME

PLASMA BIOMARKER COMPOSITION FOR DISTINGUISHING ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (AECOPD) FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND DETECTION METHOD USING SAME

机译:用于区分慢性阻塞性肺疾病(COPD)和慢性阻塞性肺疾病(AECOPD)急性加重的血浆生物标志物组成及使用相同方法的检测方法

摘要

The present invention relates to a plasma biomarker composition for distinguishing acute exacerbation of chronic obstructive pulmonary disease (AECOPD) from chronic obstructive pulmonary disease (COPD) and a detection method using the same. The present invention provides a plasma biomarker composition for distinguishing AECOPD from COPD, comprising at least one of RAR alpha, Ninein, isoform CRA_a, A1pi, fibrinogen gamma, tyrosyl-DNA phosphodiesterase 2, T cell receptor delta chain, fibrin beta, COAC, transferrin, serpin peptidase inhibitor member 6, complement factor B preproprotein, Chain B, Crig Bound To C3c, and WD repeat-containing protein 1 isoform 1. The present invention can predict the risk of occurrence of AECOPD, distinguishably diagnose COPD patients and AECOPD patients, and be useful in the prevention, early diagnosis, and treatment of AECOPD, depending on whether the expression degree of a particular protein isolated from plasma increases or decreases.;COPYRIGHT KIPO 2014
机译:血浆生物标志物组合物及其检测方法技术领域本发明涉及一种用于区分慢性阻塞性肺病(AECOPD)和慢性阻塞性肺病(COPD)的急性加重的血浆生物标志物组合物及其使用方法。本发明提供了一种用于区分AECOPD和COPD的血浆生物标志物组合物,其包含RARα,Ninein,亚型CRA_a,A1pi,纤维蛋白原γ,酪氨酰-DNA磷酸二酯酶2,T细胞受体δ链,纤维蛋白β,COAC,转铁蛋白中的至少一种。 ,丝氨酸蛋白酶抑制剂肽酶抑制剂成员6,补体因子B前蛋白,链B,与C3c结合的Crig和含有WD重复序列的蛋白1亚型1。并根据从血浆中分离的特定蛋白质的表达程度是增加还是减少而对AECOPD的预防,早期诊断和治疗有用。; COPYRIGHT KIPO 2014

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号